Navigation Links
CMC Biologics gewinnt 2013 CMO Leadership Award für Innovation, Qualität und Zuverlässigkeit
Date:3/19/2013

SEATTLE und KOPENHAGEN, Dänemark, 19. März 2013 /PRNewswire/ -- CMC Biologics, weltweit tätiges Auftragsfertigungsunternehmen, das für technische Spitzenleistungen bei der Prozessentwicklung und cGMP-Herstellung für proteinbasierte Therapeutika bekannt ist, wurde bei einer prestigeträchtigen Zeremonie während der DCAT Week13 in New York letzte Woche von Life Science Leader für Innovation, Qualität und Zuverlässigkeit ausgezeichnet.

(Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

„CMC Biologics fühlt sich geehrt, diese prestigeträchtige Auszeichnung zu erhalten und begrüßt die Anerkennung durch Life Science Leader.  Es ist unser Ziel, unseren Kunden die höchsten Qualitätsstandards und eine hohe Zuverlässigkeit bei der Herstellung und der Entwicklung zu bieten, da dies die Grundlage für den klinischen und kommerziellen Erfolg unserer Kunden ist", erklärte Claes Glassell , Chief Executive Officer. „Das gesamte CMC Biologics Team hat sich der kontinuierlichen Verbesserung unserer gesamten Betriebsabläufe und der ständigen Innovation verschrieben, um die biopharmazeutische Herstellung auf die nächste Stufe zu bringen."

Neue pharmazeutische Produkte auf den Markt zu bringen kostet Zeit und Geld, daher sind zuverlässige und effektive Auftragsunternehmen hilfreich, da sie den Prozess optimieren. Die Life Science Leader CMO Leadership Awards sind dazu gedacht, die Leistungsträger zu ehren, die durch Umfragen unter tausenden Führungs
'/>"/>

SOURCE CMC Biologics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
4. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
5. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
6. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
7. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
8. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
9. CMC Biologics Acquires XOMAs Bay Area Manufacturing Facility
10. Global Spinal Devices and Biologics Market 2011-2015
11. Synthetic Biologics Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... for the Phase 1 study of MM-302, a ... cancer.  The results were presented today by Patricia ... session at the 2015 American Association for Cancer ... PA. Data described the safety and ...
(Date:4/20/2015)... April 20, 2015  Sigma-Aldrich Corporation (Nasdaq: ... (CR) Magazine,s list of the 100 Best Corporate ... corporate responsibility performance.  Sigma-Aldrich ranked fifth, its highest ... the list. "We are honored to ... efforts and we are extremely pleased with our ...
(Date:4/20/2015)... April 20, 2015 The preclinical contract research organization ... of drugs and safety testing of medical devices, announces that ... this week,s workshop " Drug Transporters in ADME: From the ... . The title of Dr. Hidalgo,s talk is "Modern ... session entitled "Transporter Tools of the Future." The ...
Breaking Medicine Technology:Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 2Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 3Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 4Merrimack Announces Final Clinical Results for MM-302 Phase 1 Study Demonstrating Robust Activity in Heavily Pre-Treated Patients with HER2-Positive Metastatic Breast Cancer 5Sigma-Aldrich Named to CR Magazine's 100 Best Corporate Citizens List 2Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2
... YORK, Oct. 7, 2011 Intellect Neurosciences, Inc. (OTCBB: ... clinical-stage pipeline, and multiple licenses with major pharmaceutical companies ... interview with Dr. Daniel Chain, Ph.D., Chairman and CEO ... Dr. Chain will be discussing the state ...
... Health Solutions, Inc. (NYSE: MHS ) today ... the Silver Award for Best Practices in Health Care ... healthcare accreditation organization, during the URAC 12th Annual Quality ... ) Medco,s program was selected as one ...
Cached Medicine Technology:Intellect Neurosciences CEO to be Featured on Wall Street Reporter 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 2Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection 3
(Date:4/21/2015)... 2015 CALNOC, the nation’s first nursing ... RN, FAAN, will keynote their upcoming conference – Navigating ... CA on October 26, 2015. , Dr. Burnes ... of Nurse Executives (AONE) and the first African American ... American Academy of Nursing and the National Black Nurses ...
(Date:4/21/2015)... VA (PRWEB) April 21, 2015 The Science ... as a special addition to its Lunch Break Science program. ... World of Quarks! – taking guests from the subatomic world ... form. , The Museum invites members of the community to ... the Jefferson Lab physicist. Guests will delve into the nucleus ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Renewable energy, ... a few of the Earth Day topics USM ... and national leaders debate the affect of climate change ... variety of subject matter touching on the environmental concerns ... segments will delve into sustainable lifestyles, clean air options, ...
(Date:4/21/2015)... April 21, 2015 On Saturday, May ... the rest of his team from Georgia Eye ... to End Lupus Now, being held in Piedmont Park ... Walk proved to be the largest LFA-sponsored walk in ... effort to raise funds and awareness for lupus, an ...
(Date:4/21/2015)... 21, 2015 Invictus Medical has ... Illinois university for a second innovative technology aimed ... conducive to newborn infants’ cognitive development. , “This ... problems we have identified through extensive interviews and ... George Hutchinson, Invictus Medical’s Chief Technology Officer. “We ...
Breaking Medicine News(10 mins):Health News:Nationally Recognized Nurse Leader Linda Burnes Bolton to Present Keynote Address at CALNOC Conference 2Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2
... Drug Administration is scrutinizing the claims made by a ... to the claims made by the businessman Allan Lord, he ... The Bio-Germ Protection kits contain skin lotion, a nasal spray, ... online. ,According to the company, the lotion, which is ...
... 'Transcranial Magnetic Stimulation' (TMS) maybe the way forward ... aggressive electro-shock therapy., ,Electro-Shock Therapy or ECT is ... treat severe depression for many decades. However, it can ... and requires general anesthesia. In ECT the doctors pass ...
... can prevent the spread of melanoma// and other forms of ... a chemical found in turmeric, can block a biological pathway ... The chemical in the spices inhibits a protein called nuclear ... abnormal inflammations that can lead to a number of disorders ...
... revealed that consumption of fruits, vegetables and foods high in ... risk of heart disease. ,Western cuisines are not so ... plant foods in the diet. ,10 healthy individuals were ... to each of them. The diets were a vegetarian diet ...
... be responsible for various immune deficiency syndromes, and researchers// ... two different form of immune deficiency conditions called immunoglobulin ... ,Immune deficiency syndrome may be hereditary or acquired. Hereditary ... defects in the cells and tissues that are responsible ...
... help in the brain development of foetus and infants for ... administered to pregnant women. A new study conducted by scientists ... slow down the cognitive decline in middle-aged subjects. , ... and women) with increased levels of homocysteine. This amino acid ...
Cached Medicine News:Health News:A New Product Offering protection against anthrax 2Health News:Strong Magnetic Stimulation Can Help Treating Severe Depression 2Health News:Fibre Rich Food A Boon For Lowering Cholesterol 2